Chronic kidney disease: global dimension and perspectives - PubMed (original) (raw)
Review
. 2013 Jul 20;382(9888):260-72.
doi: 10.1016/S0140-6736(13)60687-X. Epub 2013 May 31.
Affiliations
- PMID: 23727169
- DOI: 10.1016/S0140-6736(13)60687-X
Review
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al. Lancet. 2013.
Erratum in
- Lancet. 2013 Jul 20;382(9888):208
Abstract
Chronic kidney disease is defined as a reduced glomerular filtration rate, increased urinary albumin excretion, or both, and is an increasing public health issue. Prevalence is estimated to be 8-16% worldwide. Complications include increased all-cause and cardiovascular mortality, kidney-disease progression, acute kidney injury, cognitive decline, anaemia, mineral and bone disorders, and fractures. Worldwide, diabetes mellitus is the most common cause of chronic kidney disease, but in some regions other causes, such as herbal and environmental toxins, are more common. The poorest populations are at the highest risk. Screening and intervention can prevent chronic kidney disease, and where management strategies have been implemented the incidence of end-stage kidney disease has been reduced. Awareness of the disorder, however, remains low in many communities and among many physicians. Strategies to reduce burden and costs related to chronic kidney disease need to be included in national programmes for non-communicable diseases.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Comment in
- Global kidney disease - Authors' reply.
Jha V, Garcia-Garcia G. Jha V, et al. Lancet. 2013 Oct 12;382(9900):1244. doi: 10.1016/S0140-6736(13)62089-9. Lancet. 2013. PMID: 24120194 No abstract available. - Global kidney disease.
Carlini R. Carlini R. Lancet. 2013 Oct 12;382(9900):1244. doi: 10.1016/S0140-6736(13)62088-7. Lancet. 2013. PMID: 24120195 No abstract available.
Similar articles
- The impact of CKD identification in large countries: the burden of illness.
Jha V, Wang AY, Wang H. Jha V, et al. Nephrol Dial Transplant. 2012 Oct;27 Suppl 3:iii32-8. doi: 10.1093/ndt/gfs113. Nephrol Dial Transplant. 2012. PMID: 23115140 Review. - Knowledge, attitudes, and practices towards prevention and early detection of chronic kidney disease.
Khalil A, Abdalrahim M. Khalil A, et al. Int Nurs Rev. 2014 Jun;61(2):237-45. doi: 10.1111/inr.12085. Epub 2014 Feb 18. Int Nurs Rev. 2014. PMID: 24571391 - Rationale and strategies for early detection and management of diabetic kidney disease.
Radbill B, Murphy B, LeRoith D. Radbill B, et al. Mayo Clin Proc. 2008 Dec;83(12):1373-81. doi: 10.1016/S0025-6196(11)60786-6. Mayo Clin Proc. 2008. PMID: 19046557 Review. - All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan.
Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF. Wen CP, et al. Lancet. 2008 Jun 28;371(9631):2173-82. doi: 10.1016/S0140-6736(08)60952-6. Lancet. 2008. PMID: 18586172 - Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ. Packham DK, et al. Am J Kidney Dis. 2012 Jan;59(1):75-83. doi: 10.1053/j.ajkd.2011.09.017. Epub 2011 Nov 3. Am J Kidney Dis. 2012. PMID: 22051245
Cited by
- Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system.
Santoro D, Caccamo D, Lucisano S, Buemi M, Sebekova K, Teta D, De Nicola L. Santoro D, et al. Biomed Res Int. 2015;2015:145828. doi: 10.1155/2015/145828. Epub 2015 Apr 27. Biomed Res Int. 2015. PMID: 26000281 Free PMC article. Review. - The Triglyceride-Glucose Index and Obesity-Related Risk of End-Stage Kidney Disease in Austrian Adults.
Fritz J, Brozek W, Concin H, Nagel G, Kerschbaum J, Lhotta K, Ulmer H, Zitt E. Fritz J, et al. JAMA Netw Open. 2021 Mar 1;4(3):e212612. doi: 10.1001/jamanetworkopen.2021.2612. JAMA Netw Open. 2021. PMID: 33787913 Free PMC article. - Costs and healthcare use of patients with chronic kidney disease in the Northern Territory, Australia.
Chen W, Howard K, Gorham G, Abeyaratne A, Zhao Y, Adegboye O, Kangaharan N, Talukder MRR, Taylor S, Cass A; Territory Kidney Care Steering Committee. Chen W, et al. BMC Health Serv Res. 2024 Jul 9;24(1):791. doi: 10.1186/s12913-024-11258-8. BMC Health Serv Res. 2024. PMID: 38982437 Free PMC article. - Patients' and clinicians' expectations on integrative medicine Services for Diabetes: a focus group study.
Chan KW, Lee PW, Leung CPS, Chan GCW, Yiu WH, Cheung HM, Li B, Lok SWY, Li H, Xue R, Chan LYY, Leung JCK, Lam TP, Lai KN, Tang SCW. Chan KW, et al. BMC Complement Med Ther. 2020 Jul 2;20(1):205. doi: 10.1186/s12906-020-02994-5. BMC Complement Med Ther. 2020. PMID: 32615961 Free PMC article. - Mitochondrial Damage-Induced Innate Immune Activation in Vascular Smooth Muscle Cells Promotes Chronic Kidney Disease-Associated Plaque Vulnerability.
Bi X, Du C, Wang X, Wang XY, Han W, Wang Y, Qiao Y, Zhu Y, Ran L, Liu Y, Xiong J, Huang Y, Liu M, Liu C, Zeng C, Wang J, Yang K, Zhao J. Bi X, et al. Adv Sci (Weinh). 2021 Jan 6;8(5):2002738. doi: 10.1002/advs.202002738. eCollection 2021 Mar. Adv Sci (Weinh). 2021. PMID: 33717842 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical